{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T01:59:13Z","timestamp":1777687153188,"version":"3.51.4"},"reference-count":52,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2016,12,15]]},"DOI":"10.3233\/jhd-160213","type":"journal-article","created":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T00:36:15Z","timestamp":1481934975000},"page":"369-377","source":"Crossref","is-referenced-by-count":23,"title":["Plasma Cytokine Levels in Relation to\u00a0Neuropsychiatric Symptoms and Cognitive Dysfunction in Huntington\u2019s disease"],"prefix":"10.1177","volume":"5","author":[{"given":"Jos A.","family":"Bouwens","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Leiden University Medical Center, The Netherlands"},{"name":"Rodersana Center for Addiction, Oirschot, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"van Duijn","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Leiden University Medical Center, The Netherlands"},{"name":"Center for Mental Health Care Delfland, Delft, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa M.","family":"Cobbaert","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, Leiden University Medical Center, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymund A.C.","family":"Roos","sequence":"additional","affiliation":[{"name":"Department of Neurology, Leiden University Medical Center, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roos C.","family":"van der Mast","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Leiden University Medical Center, The Netherlands"},{"name":"Department of Psychiatry, CAPRI-University of Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik J.","family":"Giltay","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Leiden University Medical Center, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"2","key":"10.3233\/JHD-160213_ref1","first-page":"143","article-title":"Huntington\u2019s disease","volume":"27","author":"Walker","year":"2007","journal-title":"SeminNeurol"},{"issue":"4","key":"10.3233\/JHD-160213_ref2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/jnp.2007.19.4.441","article-title":"Psychopathology in verified Huntington\u2019s disease gene carriers","volume":"19","author":"van Duijn","year":"2007","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2-3","key":"10.3233\/JHD-160213_ref3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.psychres.2012.03.041","article-title":"Irritability in Huntington\u2019s disease","volume":"200","author":"Reedeker","year":"2012","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.3233\/JHD-160213_ref4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1176\/appi.neuropsych.11030057","article-title":"Longitudinal evaluation of neuropsychiatric symptoms in Huntington\u2019s disease","volume":"24","author":"Thompson","year":"2012","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"10.3233\/JHD-160213_ref5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","article-title":"Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: The 12-month longitudinal analysis","volume":"10","author":"Tabrizi","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.3233\/JHD-160213_ref6","doi-asserted-by":"crossref","first-page":"541259","DOI":"10.1155\/2013\/541259","article-title":"The role of the immune system in Huntington\u2019s disease","volume":"2013","author":"Ellrichmann","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"2","key":"10.3233\/JHD-160213_ref7","doi-asserted-by":"crossref","first-page":"S460","DOI":"10.1067\/mai.2003.108","article-title":"2. Cytokines and chemokines","volume":"111","author":"Borish","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.3233\/JHD-160213_ref8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 7","key":"10.3233\/JHD-160213_ref9","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington\u2019s disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"issue":"8","key":"10.3233\/JHD-160213_ref10","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J Exp Med"},{"key":"10.3233\/JHD-160213_ref11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","article-title":"Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model","volume":"44","author":"Chang","year":"2014","journal-title":"Brain Behav Immun"},{"issue":"7","key":"10.3233\/JHD-160213_ref12","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J Proteome Res"},{"issue":"7","key":"10.3233\/JHD-160213_ref13","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1179\/1743132812Y.0000000073","article-title":"Oxidative stress and inflammation biomarkers in the blood of patients with Huntington\u2019s disease","volume":"34","author":"Sanchez-Lopez","year":"2012","journal-title":"Neurol Res"},{"issue":"8","key":"10.3233\/JHD-160213_ref14","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.euroneuro.2014.05.004","article-title":"Acute-phase proteins in relation to neuropsychiatric symptoms and use of psychotropic medication in Huntington\u2019s disease","volume":"24","author":"Bouwens","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"10.3233\/JHD-160213_ref15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbi.2003.11.004","article-title":"Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and\/or interferon-alpha cancer therapy","volume":"18","author":"Capuron","year":"2004","journal-title":"Brain Behav Immun"},{"issue":"12","key":"10.3233\/JHD-160213_ref16","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archpsyc.62.12.1377","article-title":"Hostile marital interactions, proinflammatory cytokine production, and wound healing","volume":"62","author":"Kiecolt-Glaser","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"10.3233\/JHD-160213_ref17","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4088\/JCP.v64n0614","article-title":"Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy","volume":"64","author":"Kraus","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.3233\/JHD-160213_ref18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jpsychores.2013.07.012","article-title":"Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids","volume":"75","author":"Lotrich","year":"2013","journal-title":"J Psychosom Res"},{"issue":"21","key":"10.3233\/JHD-160213_ref19","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group","volume":"339","author":"McHutchison","year":"1998","journal-title":"N Engl J Med"},{"issue":"12","key":"10.3233\/JHD-160213_ref20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jamda.2013.05.009","article-title":"Proinflammatory cytokines, aging, and age-related diseases","volume":"14","author":"Michaud","year":"2013","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"10.3233\/JHD-160213_ref21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/01.mcg.0000225645.75651.b8","article-title":"Impaired anger control as an underappreciated side effect of treatments for chronic HCV infection in HIV-HCV coinfected patients","volume":"42","author":"Preau","year":"2008","journal-title":"J Clin Gastroenterol"},{"issue":"9","key":"10.3233\/JHD-160213_ref22","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.psyneuen.2004.01.002","article-title":"Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women","volume":"29","author":"Suarez","year":"2004","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.3233\/JHD-160213_ref23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0889-1591(02)00019-3","article-title":"The relation of aggression, hostility, and anger to lipopolysaccharide-stimulated tumor necrosis factor (TNF)-alpha by blood monocytes from normal men","volume":"16","author":"Suarez","year":"2002","journal-title":"Brain Behav Immun"},{"issue":"2","key":"10.3233\/JHD-160213_ref24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.genhosppsych.2007.11.005","article-title":"Behavioural problems in Huntington\u2019s disease using the Problem Behaviours Assessment","volume":"30","author":"Kingma","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"issue":"9822","key":"10.3233\/JHD-160213_ref25","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","article-title":"Interleukin-6 receptor pathways in coronary heart disease: A collaborative meta-analysis of 82 studies","volume":"379","author":"Sarwar","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"10.3233\/JHD-160213_ref26","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1161\/01.STR.24.11.1625","article-title":"Apathy following cerebrovascular lesions","volume":"24","author":"Starkstein","year":"1993","journal-title":"Stroke"},{"issue":"3","key":"10.3233\/JHD-160213_ref27","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1176\/jnp.17.3.378","article-title":"A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington\u2019s disease","volume":"17","author":"Chatterjee","year":"2005","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"10.3233\/JHD-160213_ref28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JHD-160213_ref29","unstructured":"Hodges JR . Initiation: Verbal fluency tests. Cognitive Assessment for Clinicians: Oxford University Press, Oxford, United Kingdom.; 2003. pp. 118\u20139."},{"key":"10.3233\/JHD-160213_ref30","first-page":"83","article-title":"The Symbol Digit Modalities Test: A neuropsychological test for economic screening of learning and other cerebral disorders","volume":"3","author":"Smith","year":"1968","journal-title":"Learn Disord"},{"key":"10.3233\/JHD-160213_ref31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/h0054651","article-title":"Studies of interference in serial verbal reactions","volume":"18","author":"Stroop","year":"1935","journal-title":"J Exp Psychol"},{"key":"10.3233\/JHD-160213_ref32","doi-asserted-by":"crossref","unstructured":"Unified Huntington\u2019s disease rating scale: Reliability and consistency. Huntington Study Group. Mov Disord. 1996;11(2):136\u201342.","DOI":"10.1002\/mds.870110204"},{"issue":"3","key":"10.3233\/JHD-160213_ref33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2650621","article-title":"Interleukin-6 and the acute phase response","volume":"265","author":"Heinrich","year":"1990","journal-title":"Biochem J"},{"issue":"4","key":"10.3233\/JHD-160213_ref34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/clpt.2009.313","article-title":"Interleukin-6 as a therapeutic target in candidate inflammatory diseases","volume":"87","author":"Nishimoto","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.3233\/JHD-160213_ref35","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.3233\/JHD-160213_ref36","first-page":"1690","article-title":"Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans","volume":"77","author":"Mastorakos","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.3233\/JHD-160213_ref37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood.V83.1.113.113","article-title":"Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55","volume":"83","author":"Tilg","year":"1994","journal-title":"Blood"},{"issue":"6","key":"10.3233\/JHD-160213_ref38","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.smim.2013.10.008","article-title":"Treating inflammation by blocking interleukin-1 in humans","volume":"25","author":"Dinarello","year":"2013","journal-title":"Semin Immunol"},{"issue":"1","key":"10.3233\/JHD-160213_ref39","first-page":"16","article-title":"Maintaining brain health by monitoring inflammatory processes: A mechanism to promote successful aging","volume":"3","author":"Rosano","year":"2012","journal-title":"Aging Dis"},{"issue":"8","key":"10.3233\/JHD-160213_ref40","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2174\/1381612053381684","article-title":"Blood-brain barrier transport of cytokines: A mechanism for neuropathology","volume":"11","author":"Banks","year":"2005","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.3233\/JHD-160213_ref41","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0166-2236(00)02088-9","article-title":"Cytokine-induced sickness behaviour: Mechanisms and implications","volume":"25","author":"Konsman","year":"2002","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.3233\/JHD-160213_ref42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-5728(95)00148-4","article-title":"The influence of cytokines on the integrity of the blood-brain barrier in vitro","volume":"64","author":"de Vries","year":"1996","journal-title":"J Neuroimmunol"},{"issue":"12","key":"10.3233\/JHD-160213_ref43","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1172\/JCI119846","article-title":"Pathways and mechanisms for cytokine signaling of the central nervous system","volume":"100","author":"Licinio","year":"1997","journal-title":"J Clin Invest"},{"issue":"2","key":"10.3233\/JHD-160213_ref44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/glia.10161","article-title":"Microglia as a source and target of cytokines","volume":"40","author":"Hanisch","year":"2002","journal-title":"Glia"},{"issue":"1","key":"10.3233\/JHD-160213_ref45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","article-title":"Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases","volume":"87","author":"Smith","year":"2012","journal-title":"Brain Res Bull"},{"issue":"1-2","key":"10.3233\/JHD-160213_ref46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jneuroim.2003.10.031","article-title":"Interleukin-6 in the aging brain","volume":"147","author":"Godbout","year":"2004","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.3233\/JHD-160213_ref47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1523\/JNEUROSCI.22-02-00486.2002","article-title":"Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6","volume":"22","author":"Vallieres","year":"2002","journal-title":"J Neurosci"},{"issue":"2","key":"10.3233\/JHD-160213_ref48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2013an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"10.3233\/JHD-160213_ref49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL- A meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom Med"},{"issue":"4","key":"10.3233\/JHD-160213_ref50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/appi.neuropsych.12120399","article-title":"Neuropsychiatric symptoms and interleukin-6 serum levels in acute stroke","volume":"25","author":"Spalletta","year":"2013","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"5","key":"10.3233\/JHD-160213_ref51","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JHD-160213_ref52","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2172-10-52","article-title":"Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays","volume":"10","author":"de Jager","year":"2009","journal-title":"BMC Immunol"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-160213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:57:13Z","timestamp":1777453033000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-160213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,15]]},"references-count":52,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jhd-160213","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,15]]}}}